Clinical Trials Logo

Cerebral Lesion clinical trials

View clinical trials related to Cerebral Lesion.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04034875 Completed - Cerebral Lesion Clinical Trials

Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.

Start date: April 9, 2019
Phase: N/A
Study type: Interventional

The incidence of aggression and violent behavior is usually reported to be high after acquired brain injury, around 54%. Behaviors with verbal agression and, less frequently, physical agressions, are described. These behaviors may be linked to the dysfunction of the frontal lobes responsible for executive functions and complex social interactions, or to the dysfunction of the temporal structures that may also be responsible for increased aggression. It is interesting to note that very few scales or specific questionnaires evaluate the factors and co-variables that could lead to aggressive behavior after an acquired brain injury. Such questionnaires are very rare, and none have been validated in French. The objective of this study is to develop a questionnaire in French that aims to assess anger, hostility and aggression after acquired brain injury. The psychometric qualities of this questionnaire will be evaluated using the Rasch probabilistic model. The development of such a tool will be of major interest for clinical practice and future clinical research.

NCT ID: NCT03731104 Completed - Shock Clinical Trials

Cerebral Circulation in Critically Ill Children

CIRCU-REAPED
Start date: December 13, 2018
Phase:
Study type: Observational

The principal purpose of this study is to describe the changes in cerebral circulation (assessed by transcranial ultrasound) and oxygenation (assessed by Near InfraRed spectroscopy, NIRS) during resuscitation for hemodynamic failure (arterial hypotension or shock) in critically ill children treated with vasoactive or inotropic drugs. The secondary objectives are : i) to evaluate the association between an alteration of cerebral circulation and/or oxygenation and an alteration in macro-circulatory parameters (Mean Arterial Blood Pressure and cardiac output) or a bad outcome, ii) to study if cerebral autoregulation is impaired

NCT ID: NCT03114904 Completed - Withdrawal Syndrome Clinical Trials

Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in Cerebroses

NEUROSEV
Start date: February 27, 2016
Phase: N/A
Study type: Interventional

The withdrawal syndrome in benzodiazepines and morphine is common in intensive care, the incidence is estimated at 32.1%. Cerebrospatized patients are probably more prone to withdrawal because they require high doses of sedation. Moreover, this syndrome is probably deleterious on the cerebral hemodynamics (high point of the therapeutic management).